| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027779 |
| Receipt No. | R000031822 |
| Scientific Title | Effect on vascular endothelial function by Perilla oil |
| Date of disclosure of the study information | 2017/06/16 |
| Last modified on | 2019/12/17 (Ver. 4) |
| Basic information | ||
| Public title | Effect on vascular endothelial function by Perilla oil | |
| Acronym | Effect on vascular endothelial function by Perilla oil | |
| Scientific Title | Effect on vascular endothelial function by Perilla oil | |
| Scientific Title:Acronym | Effect on vascular endothelial function by Perilla oil | |
| Region |
|
|
| Condition | |||
| Condition | High blood pressure
Hyperlipidemia Diabetes Healthy volunteer |
||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To evaluate the effect on vascular endothelial function by Perilla oil |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Reactive hyperemia index |
| Key secondary outcomes | Blood pressure,Blood biochemical examination,
Food records, Medical examination |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Intake of Perilla oil 1cup of tablespoon / day for 1week | |
| Interventions/Control_2 | Intake of Olive oil 1cup of tablespoon / day for 1week | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.The person who has two or more risk factor of arteriosclerosis, and are untreated on arteriosclerosis.
2.Participants who receive adequate explanation for participation in this research and provide written informed consent by their own free will. |
|||
| Key exclusion criteria | 1.The person who are taking Perilla oil on daily basis
2.The person who are untreated on arteriosclerosis. 3.Judgement as being ineligible by the investigator or the physician. |
|||
| Target sample size | 12 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nanpuh hospital | ||||||
| Division name | Deparment of Clinical Application | ||||||
| Zip code | |||||||
| Address | 14-3 Nagata Kagoshima-city Kagoshima | ||||||
| TEL | 099-226-9111 | ||||||
| t-yoshinaga@nanpuh.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nanpuh hospital | ||||||
| Division name | Deparment of Clinical Application | ||||||
| Zip code | |||||||
| Address | 14-3 Nagata Kagoshima-city Kagoshima | ||||||
| TEL | 099-226-9111 | ||||||
| Homepage URL | |||||||
| t-yoshinaga@nanpuh.or.jp | |||||||
| Sponsor | |
| Institute | Nanpuh hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nanpuh hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031822 |